Obmom Launches 'OatObmom', a Convenient Health Food Made from Oats
100% Plant-Based Vegan Drink... "Taste and Nutrition Together"
Dx&Vx's family nutrition brand Obmom announced on the 29th the launch of 'Oat Obmom' as a convenient breakfast substitute.
Oat Obmom is a banana-flavored oat drink that captures the nutty flavor of oats and the sweet taste of bananas. It is available in two variants: 'Oat Obmom Original,' which focuses on protein and calcium, and a half-sugar product that is low in sugar and calories, effective for dieting.
Compared to other grains that are mostly carbohydrates, oats contain a balanced amount of protein and fat, earning them the nickname "king of grains." Oat Obmom is packaged in a convenient 190mL pack for easy consumption and portability, making it a simple option for office workers' breakfast substitutes or nutritious snacks for children.
An Obmom representative stated, “Oat Obmom is a 100% plant-based vegan drink that does not use lactose or animal-derived ingredients, allowing for comfortable consumption without any burden. We hope you enjoy a convenient breakfast with Oat Obmom, which combines both taste and nutrition.”
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Obmom is a family nutrition brand based on the microbiome, catering to infants, women in their 20s and 30s, and the whole family's well-being lifestyle. The product is developed through joint research by the Cori Italy AAT Institute and the Dx&Vx Microbiome Research Institute. It is directly produced by the Korean subsidiary, Korea Biopharm, securing competitiveness across the entire healthcare business value chain, including research and development (R&D), production, and distribution.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.